PMBCL Articles – Relapse – All Algorithm ASCT FDG-PET Flow diagram General Outcome Post-therapy Relapse Study Treatment 2014 Romejko-Jarosinska et al. Relapsed or refractory primary mediastinal B-cell lymphoma: Evaluation of outcome of a minority from 125 patients treated at a single institution 2015 El Mallawany et al. Advances in the Diagnosis and Treatment of Childhood and Adolescent B-Cell Non-Hodgkin Lymphoma 2015 Svoboda et al. Brentuximab Vedotin in Combination with Multi-Agent Chemotherapy Is Well Tolerated and Shows Promising Activity As Frontline Treatment for Primary Mediastinal B-Cell Lymphoma 2017 Zinzani et al. Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma 2018 Vardhana et al. Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant 2019 Tomassetti et al. The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma CATEGORIES All Algorithm ASCT FDG-PET Flow diagram General Outcome Post-therapy Relapse Study Treatment
